There's been a major selloff in Xeris Biopharma Holdings, Inc. ( NASDAQ:XERS ) shares in the week since it released its...
Biopharmaceutical Innovator Sees Significant Increases in Product Sales and Cash Flow
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript March 6, 2024 Xeris Biopharma Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello everyone and welcome to the Xeris fourth quarter and full year 2023 financial results […]